2017 IAM Guide Highlights Cornerstone Research Patent Professionals
Intellectual Asset Management (IAM) names Michael Keeley, Matthew Lynde, George Strong, and Mary Woodford in its list of leading expert witnesses on patent issues.
Securities and Exchange Commission v. BankAtlantic Bancorp Inc.
The jury found in favor of the defendants on all counts in this civil suit filed by the SEC.
Securities and Exchange Commission v. Ferrante
The defendant disgorged investment yields and paid a fine to resolve allegations in this case involving alleged EB-5 program fraud.
Matthew Lynde Named Intellectual Property Trailblazer by National Law Journal
Dr. Lynde received the honor for his lifetime achievements in applying advanced economic analysis to IP and patent damages.
2017 Who’s Who Legal
Cornerstone Research staff and affiliated experts were selected for the 2017 list of global leaders in competition and legal investigations.
The Future of the Markets Regime
This Cornerstone Research event in London featured competition and markets expert Rachel Merelie.
A Brave New World: What’s in Store?
Cornerstone Research hosted Stanford professor Joseph Grundfest to discuss current developments in securities regulation and litigation.
Los Angeles Women’s Forum 2017: Investing in Women and Gender Equity
Cornerstone Research hosted a networking event with Professor Kellie McElhaney of the Haas School of Business, University of California, Berkeley.
Estimating Damages in Litigation—Beyond Discounted Cash Flow
Ronnie Barnes spoke at a Cornerstone Research-sponsored interactive panel discussion in London.
SEC’s Renewed Focus On Non-GAAP Measures: 1 Year Later
In recent years, the use of non-GAAP financial measures has become more widespread.
Testifying Experts Draw Lessons from Recent Healthcare Mergers
This Cornerstone Research expert forum featured several healthcare merger experts.
Product Hopping
Pharmaceutical manufacturers have been accused of engaging in product hopping by introducing modified versions of branded drugs nearing patent expiry while simultaneously withdrawing the older drugs to hinder generic substitution.
How can we help you?
If you are looking for a publication not on our website, contact us.